Its to do with the double-blinding aspect. The drug administrators (ie, the doctors or nurses giving the doses) should not know or suspect which arm the patient is allocated to. If they do, there is the (low) potential for them to in-turn influence the patient's view of what arm they are in.
Its to do with the double-blinding aspect. The drug...
-
- There are more pages in this discussion • 2,873 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $85.80M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 24.0¢ | $969.3K | 3.648M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 34182 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 24689 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |